Preventing peripheral intravenous catheter-associated bloodstream infection: the randomised controlled trial versus the real world

Diana Egerton-Warburton, George Braitberg and Anthony Kambourakis
Med J Aust 2014; 201 (4): . || doi: 10.5694/mja14.00363
Published online: 18 August 2014

To the Editor: Debate regarding the prevention of peripheral intravenous catheter (PIVC)-associated bloodstream infection has been enriched by research and letters published in the Journal.1-3 Stuart and colleagues and Collignon and colleagues highlighted an association of long dwell times with PIVC-associated bloodstream infection.1,2 Rickard and colleagues refer to contrasting high-level evidence in a Cochrane review.3,4 We would suggest that important lessons can be learnt from both perspectives.

  • Diana Egerton-Warburton1,2
  • George Braitberg1
  • Anthony Kambourakis1

  • 1 Monash Health, Melbourne, VIC.
  • 2 Southern Clinical School, Monash University, Melbourne, VIC.

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.